DGX - Quest Diagnostics Incorporated

NYSE - Nasdaq Real Time Price. Currency in USD
101.00
-0.47 (-0.46%)
As of 10:40AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close101.47
Open101.32
Bid101.15 x 800
Ask101.19 x 1000
Day's Range100.88 - 101.45
52 Week Range78.95 - 115.64
Volume115,347
Avg. Volume1,002,227
Market Cap13.572B
Beta (3Y Monthly)0.89
PE Ratio (TTM)19.34
EPS (TTM)5.22
Earnings DateJul 23, 2019
Forward Dividend & Yield2.12 (2.09%)
Ex-Dividend Date2019-07-05
1y Target Est100.72
Trade prices are not sourced from all markets
  • Quest Diagnostics Warns 12 Million Patients May Be Impacted by Data Breach
    Meredith Videoslast month

    Quest Diagnostics Warns 12 Million Patients May Be Impacted by Data Breach

    The blood testing company experienced something similar in 2016.

  • News on the Move: Disaster Relief Bill, James Holzhauer on Jeopardy and more
    Yahoo Finance Videolast month

    News on the Move: Disaster Relief Bill, James Holzhauer on Jeopardy and more

    Yahoo Finance's Adam Shapiro fills you in on the latest news stories that you need to know.

  • Another 2.2 million patients affected by AMCA data breach
    TechCrunch2 hours ago

    Another 2.2 million patients affected by AMCA data breach

    Another clinical lab ensnared in the AMCA data breach has come forward. Clinical Pathology Laboratories (CPL) says 2.2 million patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information stolen in the previously-reported breach. Another 34,500 patients had their credit card or banking information compromised.

  • PR Newswire3 hours ago

    Quest Diagnostics Named one of the "Best Places to Work for Disability Inclusion"

    SECAUCUS, N.J. , July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality ...

  • Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services
    PR Newswire4 hours ago

    Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services

    SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y., July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors. "We are pleased to partner with Catholic Health Services, a leader in health care delivery on Long Island," said Quest Diagnostics Chairman, President and CEO Steve Rusckowski.

  • Earnings Preview: Quest Diagnostics (DGX) Q2 Earnings Expected to Decline
    Zacksyesterday

    Earnings Preview: Quest Diagnostics (DGX) Q2 Earnings Expected to Decline

    Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • PR Newswire5 days ago

    Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

    ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital health platform. Sharecare and Quest Diagnostics also intend to jointly explore the development of disease management programs and other services to empower better health.

  • Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23
    PR Newswire8 days ago

    Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23

    Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

    Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for DGX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.37 billion over the last one-month into ETFs that hold DGX are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. DGX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Women Health a Top Priority Now: 3 Stocks to Watch
    Zacks8 days ago

    Women Health a Top Priority Now: 3 Stocks to Watch

    Women's healthcare gains global importance, investors might want to keep an eye on these stocks.

  • QUEST DIAGNOSTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX
    PR Newswire25 days ago

    QUEST DIAGNOSTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

    NEW ORLEANS , June 21, 2019 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF ...

  • DGX vs. CHE: Which Stock Is the Better Value Option?
    Zacks29 days ago

    DGX vs. CHE: Which Stock Is the Better Value Option?

    DGX vs. CHE: Which Stock Is the Better Value Option?

  • Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?
    Simply Wall St.29 days ago

    Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?

    Today we'll take a closer look at Quest Diagnostics Incorporated (NYSE:DGX) from a dividend investor's perspective...

  • GuruFocus.comlast month

    Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $24. ...

    Chairman, President and CEO of Quest Diagnostics Inc (NYSE:DGX) Stephen H Rusckowski sold 244,565 shares of DGX on 06/13/2019 at an average price of $100 a share.

  • Bloomberglast month

    Debt Collector Goes Bankrupt After Health Care Data Hack

    (Bloomberg) -- Retrieval-Masters Creditors Bureau Inc., whose business was blamed for a large-scale data breach that affected millions of Quest Diagnostics Inc. customers, filed for Chapter 11 protection, citing fallout from the security issue.The company, which collects patient receivables for medical labs under the name American Medical Collection Agency, listed assets and liabilities of as much as $10 million in its bankruptcy petition filed in the Southern District of New York. It’s aiming to liquidate, the company said.Court documents cited a breach discovered in March that affected millions of people, including customers of Quest Diagnostics and Laboratory Corporation of America. Soon after, Quest, LabCorp, Conduent Inc. and CareCentrix Inc. -- American Medical’s four largest clients -- stopped doing business with the company, leading to the bankruptcy filing, according to court papers.A representative for Retrieval-Masters didn’t provide a comment.Cascading EventsThe data breach created a “cascade of events” resulting in the bankruptcy filing, Chief Executive Officer Russell H. Fuchs said in a court declaration. It incurred “enormous expenses that were beyond the ability of the debtor to bear,” he said.Those expenses included more than $3.8 million spent on mailing more than 7 million individual notices to people whose information had been potentially hacked. Fuchs personally lent the company $2.5 million to help pay for those mailings, he said in the declaration. In addition, IT professionals and consultants hired in connection with the breach had cost Retrieval-Masters about $400,000 by the time of the filing.The Elmsford, New York-based company learned of the breach after receiving notices saying a high number of credit cards tied to its web portal were connected to fraudulent charges, Fuchs said. Quest is facing a lawsuit in California and inquiry in Michigan about the breach.Retrieval-Masters has slashed staff to 25 from 113 at the end of 2018, according to court papers.Retrieval-Masters also collects non-medical consumer debt, according to its website. Fuchs founded the company in 1977 and was initially focused on small-dollar debt collections for direct-mail marketers, such as the various book-of-the-month or record clubs that predated the e-commerce boom, before transitioning into patient receivables, the declaration shows.The case is Retrieval-Masters Creditors Bureau Inc., 19-23185, U.S. Bankruptcy Court for the Southern District of New York (White Plains)(Updates to include impact on LabCorp customers.)To contact the reporter on this story: Jeremy Hill in New York at jhill273@bloomberg.netTo contact the editors responsible for this story: Rick Green at rgreen18@bloomberg.net, Nicole BullockFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study
    PR Newswirelast month

    Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study

    SECAUCUS, N.J., June 17, 2019 /PRNewswire/ -- Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight years, according to a new study from Quest Diagnostics (DGX), the world's leading provider of diagnostic information services. The new study, "Digital Behavioral Counseling in a Workforce Setting Reduces 8-Year Risk of Developing Type 2 Diabetes" (77-LB), is believed to be the first to suggest lower risk of diabetes may be sustained following participation in a time-limited digital Diabetes Prevention Program (DPP).

  • GlobeNewswirelast month

    Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Quest Diagnostics Incorporated (NYSE: DGX) and Encourages Quest Diagnostics Investors to Contact the Firm

    NEW YORK, June 09, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE:.

  • Business Wirelast month

    QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Quest Diagnostics Incorporated .

  • PR Newswirelast month

    Faruqi & Faruqi, LLP is Investigating Quest Diagnostics Incorporated (DGX) on Behalf of its Shareholders

    NEW YORK , June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated ("Quest Diagnostics" ...

  • Reuterslast month

    UPDATE 1-Opko Health says over 400,000 customers likely affected by data breach

    Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident. American Medical Collection Agency (AMCA) informed Opko Health that the compromised data may include credit card and bank account information, email addresses and other data such as address, phone number and balance information. Earlier this week, rivals Quest Diagnostics Inc and Laboratory Corporation of America Holdings also announced that they were apprised of unauthorized access to their customer data stored on AMCA system.

  • Here's Why You Should Invest in Quest Diagnostics (DGX) Stock
    Zackslast month

    Here's Why You Should Invest in Quest Diagnostics (DGX) Stock

    Quest Diagnostics (DGX) is boosting investors' optimism, courtesy of consistent positive results.

  • Senator warns of 'irreparable' consumer harm after data breach
    Yahoo Financelast month

    Senator warns of 'irreparable' consumer harm after data breach

    Senators demand answers from Quest Diagnostics and LabCorp after a data breach may have put millions of consumers' information at risk.

  • LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space
    Zackslast month

    LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space

    The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resources.